Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic‐phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY

por Hehlmann, Rüdiger, Cortes, Jorge E., Zyczynski, Teresa, Gambacorti‐Passerini, Carlo, Goldberg, Stuart L., Mauro, Michael J., Michallet, Mauricette, Simonsson, Bengt, Williams, Loretta A., Gajavelli, Srikanth, DeGutis, Irene, Sen, Ginny P., Paquette, Ron L.
Publicado 2018

First‐line treatment selection and early monitoring patterns in chronic phase‐chronic myeloid leukemia in routine clinical practice: SIMPLICITY

por Goldberg, Stuart L., Cortes, Jorge E., Gambacorti‐Passerini, Carlo, Hehlmann, Rüdiger, Khoury, H. Jean, Michallet, Mauricette, Paquette, Ron L., Simonsson, Bengt, Zyczynski, Teresa, Foreman, Aimee, Abruzzese, Elisabetta, Andorsky, David, Beeker, Aart, Cony‐Makhoul, Pascale, Hansen, Richard, Lomaia, Elza, Olavarria, Eduardo, Mauro, Michael J.
Publicado 2017